We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
House and Senate lawmakers are teaming up on an overhaul of FDA device procedures, including expanding the use of third-party quality audits. Read More
Important details on unique device identification, such as transition times, are missing from the EU’s draft medical device regulation, a major industry group says. Read More
In a 46-page draft guidance released Jan. 26, the U.S. FDA clarified a 2013 final rule that specifies how combination product manufacturers should meet both device and drug quality regulations and implement streamlined quality systems. Read More
Beginning Jan. 26, labelers of implantable, life-supporting and life-sustaining devices that are not Class III were able to register with the FDA’s Global Unique Device Identification Database. Read More
CDRH Office of Compliance Director Steve Silverman told senior staff that he was leaving the FDA last month to pursue opportunities outside the government. His last day at the agency was Jan. 16, according to an internal memo provided to GMP. Read More
Ensuring that product components and supplies are of top quality and delivered on time is key to running a successful business, and supplier qualification surveys need to be sufficiently broad to ensure a good result, an industry expert says.
Read More